Repetitive Transcranial Magnetic Stimulation Target Location Methods for Depression

Area of Science:

• Neuroscience
• Psychiatry
• Medical Technology

Background:

• Major depressive disorder (MDD) presents a significant global health challenge requiring innovative treatments.
• Repetitive transcranial magnetic stimulation (rTMS), an FDA-approved non-invasive therapy, offers a promising avenue for depression treatment.
• Current rTMS efficacy is limited by methodological weaknesses and variability in targeting the dorsolateral prefrontal cortex.

Purpose of the Study:

• To review and assess diverse rTMS target location methods developed for major depressive disorder.
• To identify factors contributing to heterogeneity in rTMS treatment efficacy.
• To provide insights for enhancing clinical outcomes in rTMS therapy for depression.

Main Methods:

• Systematic literature review of studies on rTMS target localization for MDD.
• Analysis of methodological variations in existing rTMS research.
• Assessment of different targeting strategies within the dorsolateral prefrontal cortex.

Main Results:

• Multiple rTMS target location methods for MDD have emerged over recent decades.
• Variations in stimulated targets within the dorsolateral prefrontal cortex are a key factor in treatment efficacy heterogeneity.
• Existing studies often exhibit methodological weaknesses impacting widespread clinical adoption.

Conclusions:

• Standardizing rTMS target location is crucial for improving treatment consistency and effectiveness in major depressive disorder.
• Further research is needed to refine targeting methods and overcome current methodological limitations.
• This review aims to guide clinical practice towards more reliable and effective rTMS application for depression.